相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase
Arina Kozlova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design, synthesis and biological evaluation of exiguamine A analogues as IDO1 inhibitors
Junmin Dong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
The ups, downs and new trends of IDO1 inhibitors
Shulun Chen et al.
BIOORGANIC CHEMISTRY (2021)
Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors
Rahul Singh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of pseudolaric acid A as a new Hsp90 inhibitor uncovers its potential anticancer mechanism
Jiangxin Liu et al.
BIOORGANIC CHEMISTRY (2021)
X-ray Structure-Guided Discovery of a Potent, Orally Bioavailable, Dual Human Indoleamine/Tryptophan 2,3-Dioxygenase (hIDO/hTDO) Inhibitor That Shows Activity in a Mouse Model of Parkinson's Disease
Xiang-Li Ning et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors
Guonan Cui et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Facially Amphiphilic Cholic Acid-Lysine Conjugates as Promising Antimicrobials
Poonam Singla et al.
ACS OMEGA (2020)
Discovery of Potent Inhibitors against P-Glycoprotein-Mediated Multidrug Resistance Aided by Late-Stage Functionalization of a 2-(4-(Pyridin-2-yl)phenoxy)pyridine Analogue
Yao Ma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase
Yuanyuan Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO)
Shulei Pan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective
Xi Feng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
4,6-Substituted-1 H-Indazoles as potent IDO1/TDO dual inhibitors
Lingling Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
Alexander J. Muller et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO-1) Inhibitors Based on Ortho-Naphthaquinone-Containing Natural Product
Hongchuan Zhao et al.
MOLECULES (2019)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase Inhibitors
Wangyang Tu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)
Ute F. Rohrig et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis and in vivo antitumor evaluation of an orally active potent phosphonamidate derivative targeting IDO1/IDO2/TDO
Xi Feng et al.
BIOCHEMICAL PHARMACOLOGY (2019)
N-Benzyl/Aryl Substituted Tryptanthrin as Dual Inhibitors of Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase
Dan Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase
Maria Winters et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Immune control by amino acid catabolism during tumorigenesis and therapy
Henrique Lemos et al.
NATURE REVIEWS CANCER (2019)
Structural Modification of Natural Product Tanshinone I Leading to Discovery of Novel Nitrogen-Enriched Derivatives with Enhanced Anticancer Profile and Improved Drug-like Properties
Chunyong Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
Todd A. Triplett et al.
NATURE BIOTECHNOLOGY (2018)
Discovery of indoleamine 2,3-dioxygenase inhibitors using machine learning based virtual screening
Hongao Zhang et al.
MEDCHEMCOMM (2018)
Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors
Liangkun Pan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives
Shengnan Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza (Danshen)
M. Jason Hatfield et al.
JOURNAL OF NATURAL PRODUCTS (2018)
Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold
Li-Dong Shao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors
Li-Dong Shao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indo1-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate
Stefano Crosignani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The kynurenine pathway and the brain: Challenges, controversies and promises
Robert Schwarcz et al.
NEUROPHARMACOLOGY (2017)
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health
Igor Cervenka et al.
SCIENCE (2017)
Site-selective Csp3-H aryloxylation of natural product Tanshinone IIA and its analogues
Bing Liang et al.
TETRAHEDRON LETTERS (2017)
Discovery of IDO1 Inhibitors: From Bench to Bedside
George C. Prendergast et al.
CANCER RESEARCH (2017)
Design, synthesis, and antimicrobial activities of new tanshinone IIA esters
Lin-Wei Zeng et al.
NATURAL PRODUCT RESEARCH (2016)
Cytotoxicity, hemolysis and in vivo acute toxicity of 2-hydroxy-3-anilino-1,4-naphthoquinone derivatives
Valeska Santana de Sena Pereira et al.
TOXICOLOGY REPORTS (2016)
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway
Amy B. Dounay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers
Paolo Puccetti et al.
PLOS ONE (2015)
Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues
Ivan Theate et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: Potential impact in diabetes
Xu Deng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of Tryptanthrin Derivatives as Potent Inhibitors of Indoleamine 2,3-Dioxygenase with Therapeutic Activity in Lewis Lung Cancer (LLC) Tumor-Bearing Mice
Shuangshuang Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Oxygen Insertion of o-Quinone under Catalytic Hydrogenation Conditions
Da-Li Zhang et al.
ORGANIC LETTERS (2013)
Design, synthesis and vasodilative activity of tanshinone IIA derivatives
Yue-Feng Bi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition
Ute F. Roehrig et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Synthesis and vasodilative activity of tanshinone IIA derivatives
Yue-Feng Bi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
Xiangdong Liu et al.
BLOOD (2010)
Oren-gedoku-to and its Constituents with Therapeutic Potential in Alzheimer's Disease Inhibit Indoleamine 2, 3-Dioxygenase Activity In Vitro
Cun-Jing Yu et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase
Christoph F. A. Vogel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors
Sanjeev Kumar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Helen J. Ball et al.
GENE (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Molecules in focus: Indoleamine 2,3-dioxygenase
Nicholas J. C. King et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Crystal structure of human indoleamine 2,3-dioxygenase:: Catalytic mechanism of O2 incorporation by a heme-containing dioxygenase
H Sugimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Asymmetric synthesis of 3(S),17-dihydroxytanshinone
JG Zhang et al.
TETRAHEDRON (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
分享论文
